Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002014
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Phase I Study to Evaluate the Pharmacokinetics Safety and Antiviral Effects of Concurrent Administration of Zidovudine AZT and 23-Dideoxyinosine ddI in Patients With Human Immunodeficiency Virus HIV
Sponsor:
Glaxo Wellcome
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
A Phase I Study to Evaluate the Pharmacokinetics Safety and Antiviral Effects of Concurrent Administration of Zidovudine AZT and 23-Dideoxyinosine ddI in Patients With Human Immunodeficiency Virus HIV
Status:
COMPLETED
Status Verified Date:
1991-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine the safety and tolerance of various combinations of zidovudine AZT and didanosine ddI administered concurrently To determine the pharmacokinetics of concurrent AZT and ddI administered orally To evaluate the antiviral immunologic and virologic effects of AZT and ddI administered concurrently
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 01 | None | None | None |